We have several inputs forecasting change (market pivots) ranging from seasonal tendencies to an expected US dollar rally, Fed monetary tightening (such as it is), the 30 month S&P 500 cycle, not to mention a presidential administration in utter disarray and not having done much, if anything, to further the fiscal stimulation (which, the story goes, would replace the Fed’s monetary stimulation under the previous administration) view that much of the stock market’s post-election euphoria was built upon.

In other words, we have working plans for two main themes; a correction in the stock market and in the mirror, a tradable rally in the gold sector. Based on an email exchange with a subscriber, I want to be clear that yes, I think the stock market has probably topped out for something more than a routine pullback; but no, we do not have the all-clear on that from a technical confirmation standpoint just yet, although the sector breakdowns noted in a Friday update held that status to close the week.

As for the precious metals, gold shot above and closed below our 1^st target of 1300 on Friday and HUI broke above, and closed below short-term resistance. Despite that little head fake the sector is constructive insofar as the stock market seemed to change character and did not put on an op/ex Friday relief (short covering) rally, implying a waning of confidence. But the gold sector has not technically confirmed.

US Stock Market

This chart shows what I mean about “seeking confirmations”. Who’s broken down? The Dow? It is above the SMA 50. Semis? What if just maybe that is a Symmetrical Triangle targeting much higher levels? Small Caps? Bear biased but no breakdown.

In TA it is absolutely important to have facts to go with opinions. My opinion is that a correction is beginning, not ending. But the facts are that not one of the items above is broken down in standard technical terms. Although in a Friday update we did note XLV to be in a breakdown posture with a target of 75. This chart would expand that to 74 (SMA 200) to 76 (trend line).

Looking closer at Healthcare, we see strong lateral support for XLV at 75 , a reasonable target for Devices (which I’ve taken the liberty to short since we’d taken the liberty of being quite bullish the sector a year ago) is around 150 (assuming a market pullback) and we can still anticipate 290 to 295 on the Biotech ETF.

Here is said Biotech ETF and some of its top components looking for lower levels (with Biogen in a relative still-bullish state).

The Device sector has been following MDT into breakdown mode. TMO in particular, looks like it is setting up for significantly lower levels. I shorted the ETF rather than individual companies to back out individual company risk. I tend not to be that sort of gung ho player from the short side. But boy, that TMO looks toppy.

NFTRH 461 then covered the balance of the US stock market (Financials, Industrials, Technology, Materials, Energy, Transports, Utilities and Consumer Staples & Discretionary before moving on to Market Internals, a detailed look at 18 different global markets, commodities, precious metals, currencies, bonds, sentiment and well, the whole shootin’ match.

Subscribe to NFTRH Premium for your 40-55 page weekly report, interim updates and NFTRH+ chart and trade ideas or the free eLetter for an introduction to our work. Or simply keep up to date with plenty of public content at NFTRH.com and Biiwii.com. Also, you can follow via Twitter ;@BiiwiiNFTRH, StockTwits, RSS or sign up to receive posts directly by email (right sidebar).

By Gary Tanashian

http://biiwii.com

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.

Gary Tanashian Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.